| 000 | 01291 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516013925.0 | ||
| 264 | 0 | _c20110110 | |
| 008 | 201101s 0 0 pol d | ||
| 022 | _a0023-2157 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMrugacz, Małgorzata | |
| 245 | 0 | 0 |
_a[Ocular findings in hepatitis C patients treated with interferon]. _h[electronic resource] |
| 260 |
_bKlinika oczna _c2010 |
||
| 300 |
_a253-6 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDry Eye Syndromes _xchemically induced |
| 650 | 0 | 4 |
_aEye Diseases _xchemically induced |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xadministration & dosage |
| 650 | 0 | 4 |
_aKeratoconjunctivitis _xchemically induced |
| 650 | 0 | 4 |
_aRetinal Artery Occlusion _xchemically induced |
| 650 | 0 | 4 |
_aRetinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xchemically induced |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aScleritis _xchemically induced |
| 650 | 0 | 4 |
_aUveitis _xchemically induced |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aLebensztejn, Dariusz | |
| 773 | 0 |
_tKlinika oczna _gvol. 112 _gno. 7-9 _gp. 253-6 |
|
| 999 |
_c20413098 _d20413098 |
||